ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

XLO Xilio Therapeutics Inc

1.06
0.01 (0.95%)
Last Updated: 23:42:11
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Xilio Therapeutics Inc XLO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.01 0.95% 1.06 23:42:11
Open Price Low Price High Price Close Price Previous Close
1.05 1.05 1.08 1.05
more quote information »

Recent News

Date Time Source Heading
02/4/202407:05GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
28/3/202422:05GLOBEXilio Therapeutics Announces $11.3 Million Private Placement..
28/3/202422:00BWGilead and Xilio Announce Exclusive License Agreement for..
29/2/202408:01GLOBEXilio Therapeutics to Participate in Novel Immuno-Oncology..
01/2/202408:01GLOBEXilio Therapeutics to Present at Guggenheim 6th Annual..
20/1/202408:30EDGAR2Form 8-K - Current report
08/1/202423:30GLOBEXilio Therapeutics Highlights Recent Advances Across..
04/1/202408:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:05EDGAR2Form 8-K - Current report
07/12/202323:45EDGAR2Form 8-K - Current report
07/12/202323:30GLOBEXilio Therapeutics Announces Initiation of Enrollment for..
10/11/202308:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202308:13EDGAR2Form 8-K - Current report
10/11/202308:10EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
10/11/202308:08EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
10/11/202308:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
10/11/202308:01GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
04/11/202307:05EDGAR2Form 8-K - Current report
04/11/202303:00GLOBEXilio Announces Initial Monotherapy Safety and Anti-Tumor..
01/11/202300:15GLOBEXilio to Host Virtual Investor Conference Call and Webcast..
28/9/202307:02GLOBEXilio Therapeutics Announces Upcoming Presentations at the..
08/9/202306:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202306:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/9/202322:35EDGAR2Form 8-K - Current report
05/9/202322:30GLOBEXilio Therapeutics Announces Promotion of Katarina..
05/9/202321:30GLOBEXilio Therapeutics to Present at Morgan Stanley 21st Annual..
19/8/202310:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202310:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202321:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202321:40EDGAR2Form 8-K - Current report
14/8/202321:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
08/8/202306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202306:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/8/202306:15EDGAR2Form 8-K - Current report
04/8/202306:05GLOBEXilio Therapeutics Announces Promotion of Chris Frankenfield..
26/5/202307:01GLOBEXilio Therapeutics Announces Preliminary Clinical Data from..
09/5/202321:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..

Your Recent History

Delayed Upgrade Clock